CN105902827A - 提高人体免疫力的中药组合物及其制备方法 - Google Patents
提高人体免疫力的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN105902827A CN105902827A CN201610310558.9A CN201610310558A CN105902827A CN 105902827 A CN105902827 A CN 105902827A CN 201610310558 A CN201610310558 A CN 201610310558A CN 105902827 A CN105902827 A CN 105902827A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 66
- 230000036039 immunity Effects 0.000 title claims abstract description 56
- 239000000203 mixture Substances 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 37
- 238000000605 extraction Methods 0.000 claims abstract description 45
- 239000009636 Huang Qi Substances 0.000 claims abstract description 29
- 241000222336 Ganoderma Species 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000002994 raw material Substances 0.000 claims abstract description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 5
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 54
- 239000000047 product Substances 0.000 claims description 31
- 240000002769 Morchella esculenta Species 0.000 claims description 26
- 235000002779 Morchella esculenta Nutrition 0.000 claims description 26
- 241000628997 Flos Species 0.000 claims description 25
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 24
- 238000000874 microwave-assisted extraction Methods 0.000 claims description 20
- 230000008569 process Effects 0.000 claims description 20
- 238000001914 filtration Methods 0.000 claims description 19
- 239000003643 water by type Substances 0.000 claims description 19
- 239000002674 ointment Substances 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 13
- 230000033228 biological regulation Effects 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 11
- 239000012141 concentrate Substances 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 10
- 238000001291 vacuum drying Methods 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 5
- 229920001353 Dextrin Polymers 0.000 claims description 5
- 239000004375 Dextrin Substances 0.000 claims description 5
- 229930195725 Mannitol Natural products 0.000 claims description 5
- 239000002671 adjuvant Substances 0.000 claims description 5
- 235000019425 dextrin Nutrition 0.000 claims description 5
- 239000000594 mannitol Substances 0.000 claims description 5
- 235000010355 mannitol Nutrition 0.000 claims description 5
- 241000208340 Araliaceae Species 0.000 claims description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 4
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 claims description 4
- 235000008434 ginseng Nutrition 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 239000002274 desiccant Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 1
- 239000010931 gold Substances 0.000 claims 1
- 229910052737 gold Inorganic materials 0.000 claims 1
- 230000008901 benefit Effects 0.000 abstract description 9
- 239000000463 material Substances 0.000 abstract description 5
- 239000003795 chemical substances by application Substances 0.000 abstract description 4
- 239000004615 ingredient Substances 0.000 abstract description 4
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 244000236521 Bupleurum rotundifolium Species 0.000 abstract 1
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000042430 Rhodiola rosea Species 0.000 abstract 1
- 235000003713 Rhodiola rosea Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 33
- 239000000243 solution Substances 0.000 description 30
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 229940079593 drug Drugs 0.000 description 17
- 230000006870 function Effects 0.000 description 17
- 206010011224 Cough Diseases 0.000 description 15
- 201000010099 disease Diseases 0.000 description 15
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 15
- 210000003734 kidney Anatomy 0.000 description 15
- 230000001737 promoting effect Effects 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 12
- 238000011282 treatment Methods 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 206010062717 Increased upper airway secretion Diseases 0.000 description 9
- 206010037660 Pyrexia Diseases 0.000 description 9
- 208000017515 adrenocortical insufficiency Diseases 0.000 description 9
- 208000026435 phlegm Diseases 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 210000002216 heart Anatomy 0.000 description 8
- 229960000890 hydrocortisone Drugs 0.000 description 8
- 230000001717 pathogenic effect Effects 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 238000005303 weighing Methods 0.000 description 8
- 241000721047 Danaus plexippus Species 0.000 description 7
- 206010062767 Hypophysitis Diseases 0.000 description 7
- 210000004100 adrenal gland Anatomy 0.000 description 7
- 238000002512 chemotherapy Methods 0.000 description 7
- 238000004140 cleaning Methods 0.000 description 7
- 230000002708 enhancing effect Effects 0.000 description 7
- 210000000936 intestine Anatomy 0.000 description 7
- 238000005728 strengthening Methods 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 6
- 238000002649 immunization Methods 0.000 description 6
- 230000003053 immunization Effects 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 238000001959 radiotherapy Methods 0.000 description 6
- 230000003014 reinforcing effect Effects 0.000 description 6
- 208000026872 Addison Disease Diseases 0.000 description 5
- 206010010144 Completed suicide Diseases 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 5
- 208000025302 chronic primary adrenal insufficiency Diseases 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 230000001502 supplementing effect Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 231100000397 ulcer Toxicity 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 4
- 239000003470 adrenal cortex hormone Substances 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000001914 calming effect Effects 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 201000004792 malaria Diseases 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000002035 prolonged effect Effects 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 230000005778 DNA damage Effects 0.000 description 3
- 231100000277 DNA damage Toxicity 0.000 description 3
- 108091093105 Nuclear DNA Proteins 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000001919 adrenal effect Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000004698 lymphocyte Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 201000008827 tuberculosis Diseases 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 241000756943 Codonopsis Species 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000002180 anti-stress Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 230000001363 autoimmune Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 231100000315 carcinogenic Toxicity 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- -1 emerald green ketone Chemical class 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000003862 glucocorticoid Substances 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010001343 Adrenal cortical hypofunctions Diseases 0.000 description 1
- 206010001367 Adrenal insufficiency Diseases 0.000 description 1
- 208000009888 Adrenocortical Adenoma Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000002017 Autoimmune Hypophysitis Diseases 0.000 description 1
- 208000019775 Back disease Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000007519 Chimonanthus praecox Nutrition 0.000 description 1
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 1
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 206010013886 Dysaesthesia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014567 Empty Sella Syndrome Diseases 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- 244000182067 Fraxinus ornus Species 0.000 description 1
- 235000002917 Fraxinus ornus Nutrition 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021067 Hypopituitarism Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010029412 Nightmare Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000003435 Optic Neuritis Diseases 0.000 description 1
- 240000001359 Origanum dictamnus Species 0.000 description 1
- 235000015987 Origanum dictamnus Nutrition 0.000 description 1
- 235000004383 Origanum vulgare subsp. vulgare Nutrition 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 208000007913 Pituitary Neoplasms Diseases 0.000 description 1
- 208000014993 Pituitary disease Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- 206010036297 Postpartum hypopituitarism Diseases 0.000 description 1
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000035977 Rare disease Diseases 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 201000009895 Sheehan syndrome Diseases 0.000 description 1
- 206010040741 Sinus bradycardia Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241001062472 Stokellia anisodon Species 0.000 description 1
- 206010061373 Sudden Hearing Loss Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 101710147108 Tyrosinase inhibitor Proteins 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 208000015234 adrenal cortex adenoma Diseases 0.000 description 1
- 201000003354 adrenal cortical adenoma Diseases 0.000 description 1
- 208000025368 adrenal gland disease Diseases 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000002365 anti-tubercular Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 108010042362 beta-Lipotropin Proteins 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 210000004246 corpus luteum Anatomy 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 230000007585 cortical function Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 210000003372 endocrine gland Anatomy 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PQTCMBYFWMFIGM-UHFFFAOYSA-N gold silver Chemical compound [Ag].[Au] PQTCMBYFWMFIGM-UHFFFAOYSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 208000000069 hyperpigmentation Diseases 0.000 description 1
- 230000003810 hyperpigmentation Effects 0.000 description 1
- 239000000960 hypophysis hormone Substances 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 208000036546 leukodystrophy Diseases 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000003212 lipotrophic effect Effects 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000002395 mineralocorticoid Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000002746 orthostatic effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 210000003681 parotid gland Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 208000017402 pituitary gland disease Diseases 0.000 description 1
- 208000010916 pituitary tumor Diseases 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000021039 pomes Nutrition 0.000 description 1
- 208000011610 primary hypophysitis Diseases 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000008945 zhigancao decoction Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种提高人体免疫力的中药组合物及其制备方法,由以下重量份的原料组成:黄芪15~20份、羊肚菌15~20份、石斛15~20份、灵芝12~15份、杜仲12~15份、女贞子12~15份、白首乌12~15份、龟板8~10份、墨旱莲8~10份、茯苓8~10份、柴胡5~7份、玄参5~7份、金银花5~7份、西洋参5~7份、木香3~5份、红景天3~5份、麦冬3~5份、甘草1~3份和三叶青1~3份。本发明的制备方法以传统中药煎熬辅助离心技术、微波‑超声综合提取技术,以水和乙醇为主要提取剂,提取中药有效成分,提取方式简单高效。
Description
技术领域
本发明涉及一种中药组合物及其制备方法,尤其是涉及一种提高人体免疫力的中药组合物及其制备方法。
背景技术
免疫力是人体自身的防御机制,是人体识别和排除异己的生理反应。免疫力的降低是疾病发生和发展的根源之一。
肾上腺皮质功能减退症常见病因为肾上腺结核或自身免疫性肾上腺炎;少见的病因包括深部真菌感染、免疫缺陷、病毒感染、恶性肿瘤、肾上腺广泛出血、手术切除肾上腺、脑白质营养不良及POEMS病等。继发性肾上腺皮质功能减退症,最常见于长期应用超生理剂量的糖皮质激素,也可继发于下丘脑-垂体疾病,如鞍区肿瘤、自身免疫性垂体炎外伤、手术切除、产后大出血引起垂体大面积梗死坏死,即席汉综合征等。
术后机体功能虚损包括患者放疗化疗后免疫功能(细胞免疫和体液免疫)损伤,患者放疗、化疗后淋巴细胞核DNA损伤,在医疗届均为不可避免的损害,因为中药能够整体调节,从根本上调整使淋巴细胞转化率仍保持正常水平,从而明显减轻放化疗所致免疫功能损伤的程度。但是目前具有提高免疫力的药物组方较少。
申请号为201410115377.1的发明专利提供了一种提高免疫力的组合物,由以下药物制备而成:党参8g、白首6g、龟板8g、墨旱莲8g、灵芝8g、大腹皮7g、茯苓7g、柴胡6g、玄参6g、金银花6g、杜仲8g、石斛8g、西洋参6g、木香6g、红景天7g、麦冬6g、黄芪6g、甘草3g,具有显著的提高机体免疫力的作用。申请号为201410319895.5的发明专利公开了一种贞芪扶正制剂的制备方法,通过先对女贞子和黄芪进行提取,再采用高速离心法对浓缩清膏中的有效成分进行纯化,不仅提取工艺简单,可操作性强,提取效率高,而且提取的有效成分的纯度也较高起到保护骨髓肾上腺皮质和肝脏的功能,而且还可进一步提高机体的 免疫力。但是现有方案中的组方较为单一,功能不够全面。
发明内容
有鉴于此,本发明的目的是针对现有技术的不足,提供一种提高人体免疫力的中药组合物及其制备方法,解决了人体免疫力损伤问题或达到了全面提升机体免疫力的效果。
为达到上述目的,本发明采用以下技术方案:
一种提高人体免疫力的中药组合物,由以下重量份的原料组成:黄芪15~20份、羊肚菌15~20份、石斛15~20份、灵芝12~15份、杜仲12~15份、女贞子12~15份、白首乌12~15份、龟板8~10份、墨旱莲8~10份、茯苓8~10份、柴胡5~7份、玄参5~7份、金银花5~7份、西洋参5~7份、木香3~5份、红景天3~5份、麦冬3~5份、甘草1~3份和三叶青1~3份。
优选的,由以下重量份的原料组成:黄芪16份、羊肚菌18份、石斛16份、灵芝12份、杜仲12份、女贞子12份、白首乌13份、龟板8份、墨旱莲8份、茯苓9份、柴胡6份、玄参6份、金银花6份、西洋参6份、木香4份、红景天4份、麦冬4份、甘草3份和三叶青1份。
提高人体免疫力的中药组合物的制备方法,包括如下制备步骤:
1)称取黄芪、羊肚菌、石斛、灵芝、杜仲、女贞子、白首乌、龟板、墨旱莲、茯苓、柴胡、玄参、金银花、西洋参、木香、红景天和麦冬,清洗、粉碎、加入1.0~2.0倍重量份水,30~50℃浸泡1.0~1.5小时;
2)将步骤1)浸泡的原料超声提取,过滤、分别收集提取液和滤渣;
3)将步骤2)所得滤渣调节pH值为6.5~7.5,加入乙醇微波提取,收集提取液;
4)将步骤2)和步骤3)所得提取液合并、浓缩、干燥;
5)称取甘草和三叶青,清洗,超微粉至10~20μm;
6)将步骤5)所得产物加1.5~2.0倍重量份水,浸泡15~20分钟,25~30℃,1500~2000转/分钟,离心5~10分钟;
7)收集步骤6)离心所得上层清液,浓缩至含水量35~50wt%;
8)将步骤4)所得产物加入到步骤7)所得产物中,得混合药膏,加入5~10wt%的辅料,混合均匀,干燥制剂。
优选的,所述步骤2)中超声提取的具体工艺条件为:80~85℃,1200~1500瓦,提取时间30~45分钟。
优选的,所述步骤3)中微波提取的工艺条件为:65~75℃,250~300瓦,提取时间15~20分钟,料液比为1克:25~30毫升。
优选的,所述步骤4)中干燥为45~50℃,真空烘干2~3小时。
优选的,所述步骤8)中辅料为蔗糖、糊精、甘露醇和聚PEG4000中的一种或一种以上的任意组合。
优选的,所述步骤8)中的制剂包括汤剂、颗粒剂、片剂、胶囊剂、粉剂、膏剂和丸剂。
本发明的各原料组份中,每组份原料的药理及药效为:
黄芪,增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。能消除实验性肾炎蛋白尿,增强心肌收缩力,调节血糖含量。黄芪不仅能扩张冠状动脉,改善心肌供血,提高免疫功能,而且能够延缓细胞衰老的进程。黄芪食用方便,可煎汤,煎膏,浸酒,入菜肴等。
羊肚菌,有益肠胃、助消化、化痰理气、补肾壮阳、补脑提神等功效,另外还具有强身健体、预防感冒,增强人体免疫力的功效。羊肚菌含抑制肿瘤的多糖,抗菌、抗病毒的活性成分,具有增强机体免疫力、抗疲劳、抗病毒、抑制肿瘤等诸多作用。日本科学家发现羊肚菌提取液中含有酪氨酸酶抑制剂,可以有效地抑制脂褐质的形成。羊肚菌所含丰富的硒是人体红细胞谷胱甘肽过氧化酶的组成成分,可运输大量氧分子来抑制恶性肿瘤,使癌细胞失活;另方面能加强维生素E的抗氧化作用。硒的抗氧化作用能改变致癌物的代方向,并通 过结合而解毒,从而减少或消除致癌的危险。
石斛,又名万丈须。李时珍在《本草纲目》中评价石斛“强阴益精,厚肠胃,补内绝不足,平胃气,长肌肉,益智除惊,轻身延年”。
灵芝,《神农本草经》:“赤芝,味苦平。主胸中结,益心气,补中,增慧智,不忘。久食,轻身不老,延年神仙。一名丹芝。
杜仲,具有清除体内垃圾,加强人体细胞物质代谢,防止肌肉骨骼老化,平衡人体血压,分解体内胆固醇,降低体内脂肪,恢复血管弹性,利尿清热,广谱抗菌,兴奋中枢神经,提高白血球药理作用。
女贞子,具有滋补肝肾,明目乌发的功能。女贞子的特点在于药性较平和,作用缓慢,久服始能见效。现代临床上还用于视神经炎、白细胞减少症、慢性肝炎、高血脂症、冠心病、高血压、儿童中毒听力减退、神经衰弱、面神经麻痹、脱发等。女贞子药用价值高,根据《本草经疏》记载:“女贞子,气味俱阴,正入肾除热补精之要品,肾得补,则五脏自安,精神自足,百病去而身肥健矣。”
白首乌,滋补肝肾,强壮身体,养血补血,乌须黑发,收敛精气,生肌敛疮,润肠通便。主治久病虚弱,慢性风痹,腰膝酸软,贫血,肠出血,须发早白,神经衰弱,阴虚久疟,溃疡久不收口,老人便秘。性味归经《山东中药》:“味苦甘涩,性微温,无毒。”入肝,肾二经。
龟板,滋阴潜阳,益肾强骨,养血补心,固经止崩。主治用于阴虚潮热,骨蒸盗汗,头晕目眩,虚风内动,筋骨痿软,心虚健忘,崩漏经多。
墨旱莲,《本草纲目》指出墨旱莲“乌须发,益肾阴”。《本草述》认为,墨旱莲“疗溺血及肾虚变为劳淋”。在临床上,墨旱莲常与女贞子同用,旱莲草和女贞子都有保肝、解毒、降低转氨酶的作用,可以治疗肝肾阴虚,失眠心烦,耳鸣头晕,腰膝酸软等病证。
茯苓,利水渗湿,健脾,宁心。主治用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠。
柴胡,和解表里,疏肝解郁,升阳举陷,退热截疟。主治用于感冒发热,寒热往来,胸胁胀痛,月经不调,子宫脱垂,脱肛。
玄参,清热凉血;滋阴降火;解毒散结。主温热病热和营血;身热;烦渴;舌绛;发斑;骨蒸劳嗽;虚烦不寤;津伤便秘;目涩昏花;咽喉喉肿痛;瘰疬痰核;痈疽疮毒。
金银花性寒,味甘,入肺、心、胃经,具有清热解毒、抗炎、补虚疗风的功效,主治胀满下疾、温病发热,热毒痈疡和肿瘤等症。其对于头昏头晕、口干作渴、多汗烦闷、肠炎、菌痢、麻疹、肺炎、乙脑、流脑、急性乳腺炎、败血症、阑尾炎、皮肤感染、痈疽疔疮、丹毒、腮腺炎、化脓性扁桃体炎等病症均有一定疗效。
西洋参具有滋阴补气,宁神益智及清热生津,降火消暑的双重功效。古语云:“西洋参性凉而补,凡欲用人参而不受人参之温者皆可用之”。故补而不燥是西洋参的特别之处。功能主治:强化心肌及增强心脏之活动能力;强壮中枢神经,安定身心并恢复疲劳,有镇静及解酒作用,增强记忆能力,对老人痴呆症有显著功效;对血压有调整作用,使暂时性或持久性血压下降.抑制动脉硬化并促进红血球生长,增加血色素的份量;能调节胰岛之分泌,因此对糖尿病有功效;对肝脏有调节毒素之分泌,促进新陈代谢的作用;能增强体力并对运动员具极大助益;抑制癌细胞生长,增加免疫功能;助长消化,对慢性胃病和肠胃衰弱有助效。
木香,其功效:行气,止痛,健脾,消食。主治:行气止痛;调中导滞。主胞胁胀满足;脘腹胀痛;嗳吐泄泻;痢疾后重。用于胸脘胀痛、泻痢后重、 食积不消、不思饮食;中气不省;突发耳聋;蛇虫咬伤;牙痛。功能主治:脾胃气滞之脘腹胀满或疼痛,嗳气,恶心呕吐;湿浊中阻之胸闷腹胀,纳呆便溏;痰湿壅肺之咳嗽气喘;邪气,辟毒疫温鬼,强志,主淋露,久服不梦寤魇寐;消毒,杀鬼精物,温疟蛊毒,气劣气不足,肌中偏寒,引药之精。
红景天,性味:寒、甘、涩。归经:肺经。功能主治:有补气清肺、益智养心、收涩止血、散瘀消肿的功效。主治气虚体弱、病后畏寒、气短乏力、肺热咳嗽、咯血、白带腹泻、跌打损伤等。
麦冬,《神农本草经》将麦冬列为养阴润肺的上品,言其“久服轻身,不老不饥”。《本草分经》称麦冬“甘、微苦,微寒。润肺清心、泻热生津、化痰止呕、治嗽行水”。《医学衷中参西录》言其:“能入胃以养胃液,开胃进食,更能入脾以助脾散精于肺,定喘宁嗽。”中医认为,麦冬味甘、微苦,性微寒,归胃、肺、心经,有养阴润肺、益胃生津、清心除烦的功效,用于肺燥干咳、阴虚痨嗽、喉痹咽痛、津伤口渴、内热消渴、心烦失眠、肠燥便秘等症。
甘草:功效用于心气虚,心悸怔忡,脉结代,以及脾胃气虚,倦怠乏力等。前者,常与桂枝配伍,如桂枝甘草汤、炙甘草汤。后者,常与党参、白术等同用,如四君子汤、理中丸等。用于痈疽疮疡、咽喉肿痛等。可单用,内服或外敷,或配伍应用。痈疽疮疡,常与金银花、连翘等同用,共奏清热解毒之功,如仙方活命饮。咽喉肿痛,常与桔梗同用,如桔梗汤。若农药、食物中毒,常配绿豆或与防风水煎服。用于气喘咳嗽。可单用,亦可配伍其他药物应用。如治湿痰咳嗽的二陈汤;治寒痰咳喘的苓甘五味姜辛汤;治燥痰咳嗽的桑杏汤;治热毒而致肺痈咳唾腥臭脓痰的桔梗汤;治咳唾涎沫的甘草干姜汤等。另风热咳嗽、风寒咳嗽、热痰咳嗽亦常配伍应用。
三叶青:清热解毒,活血祛风。
本发明的技术方案以多味中药配伍进行综合治疗,采用中医方剂“君、臣、佐、使”理论遣方用药。
君药:黄芪增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用;羊肚菌有益肠胃、助消化、化痰理气、补肾壮阳、补脑提神等功效,另外还具有强身健体、预防感冒,增强人体免疫力的功效;石斛“强阴益精,厚肠胃,补内绝不足,平胃气,长肌肉,益智除惊,轻身延年”;灵芝益心气,补中,增慧智,不忘。久食,轻身不老,延年益寿。四药共增强机体免疫功能,并各有所长。
臣药:白首乌滋补肝肾,强壮身体,养血补血;龟板滋阴潜阳,益肾强骨,养血补心,固经止崩;墨旱莲疗溺血及肾虚变为劳淋,茯苓利水渗湿,健脾,宁心;柴胡和解表里,疏肝解郁,升阳举陷,退热截疟;玄参清热凉血;滋阴降火;解毒散结;金银花性寒,味甘,入肺、心、胃经,具有清热解毒、抗炎、补虚疗风的功效;西洋参滋阴补气,宁神益智及清热生津,降火消暑的双重功效;木香行气,止痛,健脾,消食。行气止痛;调中导滞,固本培元。这8味药共同作用疏肝解郁,滋阴补气,进一步增强了君药的益心气,补中之功效。
佐药:红景天性味,寒、甘、涩,和麦冬甘、微苦,微寒。润肺清心、泻热生津、化痰止呕、治嗽行水。与君药和臣药共同作用,进一步增强了本配方健身免疫、化痰生津的作用,使君药和臣药作用更为和谐顺畅。
甘草和三叶青为使药,性平、味甘,缓急止痛、清热解毒、活血祛风,调和诸药。君臣佐使协同作用,互为配合。
本发明的有益效果是:
本发明提高免疫力的中药组合物以多味中药配伍进行综合治疗,采用中医方剂“君、臣、佐、使”理论遣方用药。多味位中药配伍得当,取长补短,互为配 合,具有清热利湿、活血祛瘀、扶正固本等功效,能够从根本上调节人体免疫系统的功能,促使免疫系统功能的恢复与增强。适用于肾上腺皮质功能减退症常见病因为肾上腺结核或自身免疫性肾上腺炎,或者术后机体功能虚损包括患者放疗化疗后免疫功能(细胞免疫和体液免疫)均受到损伤,患者放疗、化疗后淋巴细胞核DNA损伤,具有见效快、治愈率高、复发率低、标本兼治、制备简便、成本低廉等特点。
本发明提高免疫力的中药组合物的制备工方法以传统中药煎熬辅助离心技术、微波-超声综合提取技术,以水和乙醇为主要提取剂,提取中药有效成分,提取方式简单高效。
本中草药所有选取的原料均为无毒无害的纯天然中草药,故使用本发明的高免疫力的中药组合物配方不具毒副作用,结合现有理论技术、临床经验和中药提取技术,能达到药物有效成分提取可靠,工艺过程可规模化生产,适于推广应用。
具体实施方式
以下以具体实施方式来阐述本发明的内容,并不以此限制本发明的权利要求保护的范围。
实施例1
一种提高人体免疫力的中药组合物,由以下重量份的原料组成:黄芪16份、羊肚菌18份、石斛16份、灵芝12份、杜仲12份、女贞子12份、白首乌13份、龟板8份、墨旱莲8份、茯苓9份、柴胡6份、玄参6份、金银花6份、西洋参6份、木香4份、红景天4份、麦冬4份、甘草3份和三叶青1份。
该提高人体免疫力的中药组合物的制备方法,包括如下制备步骤:
1)称取黄芪、羊肚菌、石斛、灵芝、杜仲、女贞子、白首乌、龟板、墨旱莲、茯苓、柴胡、玄参、金银花、西洋参、木香、红景天和麦冬,清洗、粉碎、 加入1.0倍重量份水,置于密闭容器内,加压,30℃浸泡1.0小时;
2)将步骤1)浸泡的原料超声提取,过滤、分别收集提取液和滤渣,超声提取的具体工艺条件为:80℃,1200瓦,提取时间30分钟;
3)将步骤2)所得滤渣调节pH值为6.5,加入乙醇微波提取,收集提取液,微波提取的工艺条件为:65℃,250瓦,提取时间15分钟,料液比1克:25毫升;
4)将步骤2)和步骤3)所得提取液合并、浓缩、45℃真空烘干2小时;
5)称取甘草和三叶青,清洗,超微粉至10μm;
6)将步骤5)所得产物加1.5倍重量份水,浸泡15分钟,25℃,1500转/分钟,离心5分钟;
7)收集步骤6)离心所得上层清液,浓缩至含水量35wt%;
8)将步骤4)所得产物加入到步骤7)所得产物中,混合药膏,加入6wt%的蔗糖,混合均匀,干燥制成颗粒剂。
实施例2
一种提高人体免疫力的中药组合物,由以下重量份的原料组成:黄芪15份、羊肚菌15份、石斛15份、灵芝12份、杜仲12份、女贞子12份、白首乌12份、龟板8份、墨旱莲8份、茯苓8份、柴胡5份、玄参5份、金银花5份、西洋参5份、木香3份、红景天3份、麦冬3份、甘草1份和三叶青1份。
该提高人体免疫力的中药组合物的制备方法,包括如下制备步骤:
1)称取黄芪、羊肚菌、石斛、灵芝、杜仲、女贞子、白首乌、龟板、墨旱莲、茯苓、柴胡、玄参、金银花、西洋参、木香、红景天和麦冬,清洗、粉碎、加入1.2倍重量份水,32℃浸泡1.1小时;
2)将步骤1)浸泡的原料超声提取,用30~45μm膜过滤处理、分别收集提取液和滤渣,超声提取的具体工艺条件为:81℃,1250瓦,提取时间31分钟;
3)将步骤2)所得滤渣调节pH值为6.7,加入乙醇微波提取,收集提取液,微波提取的工艺条件为:67℃,260瓦,提取时间16分钟,料液比为1克:26毫升;
4)将步骤2)和步骤3)所得提取液合并、浓缩、46℃真空烘干2.2小时;
5)称取甘草和三叶青,清洗,超微粉至12μm;
6)将步骤5)所得产物加1.6倍重量份水,浸泡16分钟,26℃,2000转/分钟,离心6分钟;
7)收集步骤6)离心所得上层清液、浓缩至含水量38wt%;
8)将步骤4)所得产物加入到步骤7)所得产物中,得混合药膏,加入8wt%的甘露醇混合均匀、干燥制成汤剂。
实施例3
一种提高人体免疫力的中药组合物,由以下重量份的原料组成:黄芪16份、羊肚菌18份、石斛16份、灵芝12份、杜仲12份、女贞子12份、白首乌13份、龟板8份、墨旱莲8份、茯苓9份、柴胡6份、玄参6份、金银花6份、西洋参6份、木香4份、红景天4份、麦冬4份、甘草3份和三叶青1份。
该提高人体免疫力的中药组合物的制备方法,包括如下制备步骤:
1)称取黄芪、羊肚菌、石斛、灵芝、杜仲、女贞子、白首乌、龟板、墨旱莲、茯苓、柴胡、玄参、金银花、西洋参、木香、红景天和麦冬,清洗、粉碎、加入1.4倍重量份水,34℃浸泡1.2小时;
2)将步骤1)浸泡的原料超声提取,过滤、分别收集提取液和滤渣,超声提取的具体工艺条件为:82℃,1350瓦,提取时间35分钟;
3)将步骤2)所得滤渣调节pH值为6.9,加入乙醇微波提取,收集提取液,微波提取的工艺条件为:69℃,270瓦,提取时间17分钟,料液比为1克:27毫升;
4)将步骤2)和步骤3)所得提取液合并、浓缩、47℃真空烘干2.4小时;
5)称取甘草和三叶青,清洗,超微粉至14μm;
6)将步骤5)所得产物加1.7倍重量份水,浸泡17分钟,27℃,1750转/分钟,离心7分钟;
7)收集步骤6)离心所得上层清液、浓缩至含水量40wt%;
8)将步骤4)所得产物加入到步骤7)所得产物中,得混合药膏,加入7wt%的PEG4000,干燥制成胶囊剂。
实施例4
一种提高人体免疫力的中药组合物,由以下重量份的原料组成:黄芪17份、羊肚菌17份、石斛17份、灵芝14份、杜仲14份、女贞子14份、白首乌14份、龟板10份、墨旱莲10份、茯苓10份、柴胡7份、玄参7份、金银花7份、西洋参7份、木香5份、红景天5份、麦冬5份、甘草3份和三叶青3份。
该提高人体免疫力的中药组合物的制备方法,包括如下制备步骤:
1)称取黄芪、羊肚菌、石斛、灵芝、杜仲、女贞子、白首乌、龟板、墨旱莲、茯苓、柴胡、玄参、金银花、西洋参、木香、红景天和麦冬,清洗、粉碎、加入1.6倍重量份水,38℃浸泡1.3小时;
2)将步骤1)浸泡的原料超声提取,过滤、分别收集提取液和滤渣,超声提取的具体工艺条件为:83℃,1400瓦,提取时间38分钟;
3)将步骤2)所得滤渣调节pH值为7.0,加入乙醇微波提取,收集提取液,微波提取的工艺条件为:70℃,280瓦,提取时间18分钟,料液比为1克:28毫升;
4)将步骤2)和步骤3)所得提取液合并、浓缩、48℃真空烘干2.6小时;
5)称取甘草和三叶青,清洗,超微粉至16μm;
6)将步骤5)所得产物加1.8倍重量份水,浸泡18分钟,28℃,1600转/分钟,离心8分钟;
7)收集步骤6)离心所得上层清液、浓缩至含水量42wt%;
8)将步骤4)所得产物加入到步骤7)所得产物中,得混合药膏,加入重量比为1:1的蔗糖和糊精7wt%,混合均匀,干燥制成粉剂。
实施例5
一种提高人体免疫力的中药组合物,由以下重量份的原料组成:黄芪19份、羊肚菌19份、石斛19份、灵芝15份、杜仲15份、女贞子15份、白首乌15份、龟板8份、墨旱莲8份、茯苓8份、柴胡5份、玄参5份、金银花5份、西洋参5份、木香3份、红景天3份、麦冬3份、甘草1份和三叶青1份。
该提高人体免疫力的中药组合物的制备方法,包括如下制备步骤:
1)称取黄芪、羊肚菌、石斛、灵芝、杜仲、女贞子、白首乌、龟板、墨旱莲、茯苓、柴胡、玄参、金银花、西洋参、木香、红景天和麦冬,清洗、粉碎、加入1.8倍重量份水,40℃浸泡1.4小时;
2)将步骤1)浸泡的原料超声提取,过滤、分别收集提取液和滤渣,超声提取的具体工艺条件为:84℃,1450瓦,提取时间40分钟;
3)将步骤2)所得滤渣调节pH值为7.1,加入乙醇微波提取,收集提取液,微波提取的工艺条件为:71℃,290瓦,提取时间19分钟,料液比为1克:29毫升;
4)将步骤2)和步骤3)所得提取液合并、浓缩、49℃真空烘干2.7小时;
5)称取甘草和三叶青,清洗,超微粉至18μm;
6)将步骤5)所得产物加1.9倍重量份水,浸泡19分钟,29℃,1700转/分钟,离心9分钟;
7)收集步骤6)离心所得上层清液、浓缩至含水量44wt%;
8)将步骤4)所得产物加入到步骤7)所得产物中,得混合药膏,加入重量比为1:2:1的蔗糖、糊精和甘露醇8wt%混合均匀,干燥制成丸剂。
实施例6
一种提高人体免疫力的中药组合物,由以下重量份的原料组成:黄芪20份、羊肚菌20份、石斛20份、灵芝12份、杜仲12份、女贞子12份、白首乌12份、龟板8份、墨旱莲8份、茯苓8份、柴胡5份、玄参5份、金银花5份、西洋参5份、木香3份、红景天3份、麦冬3份、甘草1份和三叶青1份。
该提高人体免疫力的中药组合物的制备方法,包括如下制备步骤:
1)称取黄芪、羊肚菌、石斛、灵芝、杜仲、女贞子、白首乌、龟板、墨旱莲、茯苓、柴胡、玄参、金银花、西洋参、木香、红景天和麦冬,清洗、粉碎、加入1.9倍重量份水,44℃浸泡1.5小时;
2)将步骤1)浸泡的原料超声提取,过滤、分别收集提取液和滤渣,超声 提取的具体工艺条件为:85℃,1500瓦,提取时间42分钟;
3)将步骤2)所得滤渣调节pH值为7.2,加入乙醇微波提取,收集提取液,微波提取的工艺条件为:72℃,300瓦,提取时间20分钟,料液比为1克:30毫升;
4)将步骤2)和步骤3)所得提取液合并、浓缩、50℃真空烘干2.8小时;
5)称取甘草和三叶青,清洗,超微粉至19μm;
6)将步骤5)所得产物加2.0倍重量份水,浸泡20分钟,30℃,1800转/分钟,离心10分钟;
7)收集步骤6)离心所得上层清液、浓缩至含水量46wt%;
8)将步骤4)所得产物加入到步骤7)所得产物中,得混合药膏,加入重量比为1:2的蔗糖和聚PEG4000 9wt%混合均匀,干燥制成膏剂。
实施例7
一种提高人体免疫力的中药组合物,由以下重量份的原料组成:黄芪15份、羊肚菌16份、石斛17份、灵芝12份、杜仲12份、女贞子12份、白首乌12份、龟板8份、墨旱莲8份、茯苓8份、柴胡5份、玄参5份、金银花5份、西洋参5份、木香3份、红景天3份、麦冬3份、甘草1份和三叶青1份。
该提高人体免疫力的中药组合物的制备方法,包括如下制备步骤:
1)称取黄芪、羊肚菌、石斛、灵芝、杜仲、女贞子、白首乌、龟板、墨旱莲、茯苓、柴胡、玄参、金银花、西洋参、木香、红景天和麦冬,清洗、粉碎、加入2.0倍重量份水,46℃浸泡1.1小时;
2)将步骤1)浸泡的原料超声提取,过滤、分别收集提取液和滤渣,超声提取的具体工艺条件为:81℃,1220瓦,提取时间44分钟;
3)将步骤2)所得滤渣调节pH值为7.4,加入乙醇微波提取,收集提取液,微波提取的工艺条件为:74℃,260瓦,提取时间17分钟,料液比为1克:26毫升;
4)将步骤2)和步骤3)所得提取液合并、浓缩、45℃真空烘干3小时;
5)称取甘草和三叶青,清洗,超微粉至20μm;
6)将步骤5)所得产物加水1.5倍重量份,浸泡15分钟,25℃,1900转/分钟,离心5分钟;
7)收集步骤6)离心所得上层清液、浓缩至含水量48wt%;
8)将步骤4)所得产物加入到步骤7)所得产物中,得混合药膏,加入5wt%的甘露醇,混合均匀,干燥,加入适量的盐酸调节酸度,经配置,滤过,灌封,灭菌和检漏制成注射剂。以甘露醇为辅料制成的注射剂特别适用于因糖尿病引起的免疫功能低下的并发症,直接注射给药效果更佳。
实施例8
一种提高人体免疫力的中药组合物,由以下重量份的原料组成:黄芪20份、羊肚菌18份、石斛16份、灵芝15份、杜仲13份、女贞子13份、白首乌13份、龟板8份、墨旱莲8份、茯苓10份、柴胡5份、玄参5份、金银花5份、西洋参5份、木香3份、红景天3份、麦冬3份、甘草3份和三叶青1份。
该提高人体免疫力的中药组合物的制备方法,包括如下制备步骤:
1)称取黄芪、羊肚菌、石斛、灵芝、杜仲、女贞子、白首乌、龟板、墨旱莲、茯苓、柴胡、玄参、金银花、西洋参、木香、红景天和麦冬,清洗、粉碎、加入1.9倍重量份水,50℃浸泡1.5小时;
2)将步骤1)浸泡的原料超声提取,过滤、分别收集提取液和滤渣,超声提取的具体工艺条件为:82℃,1320瓦,提取时间45分钟;
3)将步骤2)所得滤渣调节pH值为7.5,加入乙醇微波提取,收集提取液,微波提取的工艺条件为:75℃,300瓦,提取时间20分钟,料液比为1克:30毫升;
4)将步骤2)和步骤3)所得提取液合并、浓缩、50℃真空烘干3小时;
5)称取甘草和三叶青,清洗,超微粉至20μm;
6)将步骤5)所得产物加2.0倍重量份水,浸泡20分钟,30℃,2000转/分钟,离心10分钟;
7)收集步骤6)离心所得上层清液、浓缩至含水量50wt%;
8)将步骤4)所得产物加入到步骤7)所得产物中,得混合药膏,加入10wt%糊精,混合均匀,干燥制成丸剂。
为了说明本发明对治疗肾上腺皮质功能减退症的疗效,进行了临床治疗实验,其临床数据如下:
肾上腺皮质功能减退症可分为原发性和特发性两大类。原发性肾上腺皮质功能减退症又称为艾迪生病,1855年Thomas Addison“发表《论肾上腺疾病对全身和局部的影响》,描写了以进行性贫血、皮肤褐色色素沉着、肌肉无力、极度衰弱、血压降低等为特征的疾病,即后来以他的姓氏命名的艾迪生病。
艾迪生病主要是由于自身免疫、感染等原因破坏了双侧肾上腺皮质的绝大部分而引起肾上腺皮质激素分泌不足所致,多同时有肾上腺糖皮质激素皮质醉和盐皮质激素醛固酮分泌不足的表现。特发性者是由于下丘脑一垂体病变或使用肾上腺皮质激素治疗引起促肾上腺皮质激素不足导致肾上腺皮质激素分泌减少。
原发性和特发性肾上腺皮质功能减退症有很多相同的临床特点,他们之间的不同主要是色素沉着。黑素细胞是导致色素沉着的原因,血浆皮质醇减少导致垂体产生增加促脂素,因促脂素有色素细胞兴奋活性,产生艾迪生病特征性皮肤和粘膜过度色素沉着。
一、治疗肾上腺皮质功能减退症的临床研究:
二、资料与方法
1.病例资料
临床表现症状以色素沉着、食欲减退、疲乏无力为早期表现,并有头晕、体位性低血压、恶心、呕吐、腹胀、腹痛、腹泻、体重减轻、性欲减退,阴毛腋毛稀疏、阳痰等实验室检查可有多种改变,包括激素水平、血常规血电解质等异常 心电图有改变、窦性心动过缓等改变。肾上腺和垂体磁共振的异常。根据临床表现及辅助检查诊断为肾上腺皮质功能减退症共40例,其中男性20例,女性20例,年龄最21小岁,最大70岁。
2.研究指标
附表1 40例患者的部分临床资料和辅助检查
注(表格中肾上腺垂体磁共振项中,无殊为肾上腺垂体磁共振检查无异常,-为无肾上腺垂体磁共震检查,其他为肾上腺垂体磁共振映像表现)。
所有确诊患者,随机分为对照组和实验组,每组20例患者。对照组20例患者均服用氢化可的松。肾上腺结核者,在氢化可的松治疗的同时需要积极给予抗结核治疗;特发性肾上腺皮质功能减退症患者(即表中所述特发性、空泡蝶鞍),在给予氢化可的松的同时需要给予甲状腺素治疗;因垂体激素缺乏患者(即表中所述垂体瘤术后、POMES),服用氢化可的松的同时需要同时服用相应激素辅助治疗;肾上腺皮质腺瘤切除术后、多发性内分泌腺功能减退症状的男性患者服用氢化可的松的同时肌注人绒毛膜促性腺激素、丙酸梁丸酮或十一酸翠酮促进疗效,席汗综合症症状的女性患者服用氢化可的松的同时使用雌激素和黄体酮进行人工周期治疗,病人临床症状都有不同程度好转。实验组以本发明实施例3所得提高人体免疫力的中药组合物颗粒剂代替氢化可的松治疗,其他均相同。以下通过附表说明本发明所得提高人体免疫力的中药组合物的有效效果。
附表2:效果对比
痊愈 | 显效 | 有效 | 无效 | 合计 | |
对比组 | 5 | 10 | 5 | 0 | 20 |
实验组 | 10 | 8 | 2 | 0 | 20 |
通过附表2说明本发明获得的提高人体免疫力的中药组合物与药物配合能够有效治疗肾上腺皮质功能减退症,且疗效显著,与现有药物肾上腺皮质激素氢化可的松相比,明显具有更好的治疗效果。
同样,本发明提高人体免疫力的中药组合物在治疗术后机体功能虚损包括患者放疗化疗后免疫功能(细胞免疫和体液免疫)损伤,患者放疗、化疗后淋巴细胞核DNA损伤等方面疗效也很突出,这里不再一一赘述。
最后说明的是,以上实施例仅用以说明本发明的技术方案而非限制,本领域普通技术人员对本发明的技术方案所做的其他修改或者等同替换,只要不脱离本发明技术方案的精神和范围,均应涵盖在本发明的权利要求范围当中 。
Claims (8)
1.一种提高人体免疫力的中药组合物,其特征在于,由以下重量份的原料组成:黄芪15~20份、羊肚菌15~20份、石斛15~20份、灵芝12~15份、杜仲12~15份、女贞子12~15份、白首乌12~15份、龟板8~10份、墨旱莲8~10份、茯苓8~10份、柴胡5~7份、玄参5~7份、金银花5~7份、西洋参5~7份、木香3~5份、红景天3~5份、麦冬3~5份、甘草1~3份和三叶青1~3份。
2.根据权利要求1所述的一种提高人体免疫力的中药组合物,其特征在于,由以下重量份的原料组成:黄芪16份、羊肚菌18份、石斛16份、灵芝12份、杜仲12份、女贞子12份、白首乌13份、龟板8份、墨旱莲8份、茯苓9份、柴胡6份、玄参6份、金银花6份、西洋参6份、木香4份、红景天4份、麦冬4份、甘草3份和三叶青1份。
3.一种根据权利要求1或2所述的提高人体免疫力的中药组合物的制备方法,其特征在于,包括如下制备步骤:
1)称取黄芪、羊肚菌、石斛、灵芝、杜仲、女贞子、白首乌、龟板、墨旱莲、茯苓、柴胡、玄参、金银花、西洋参、木香、红景天和麦冬,清洗、粉碎、加入1.0~2.0倍重量份水,30~50℃浸泡1.0~1.5小时;
2)将步骤1)浸泡的原料超声提取,过滤、分别收集提取液和滤渣;
3)将步骤2)所得滤渣调节pH值为6.5~7.5,加入乙醇微波提取,收集提取液;
4)将步骤2)和步骤3)所得提取液合并、浓缩、干燥;
5)称取甘草和三叶青,清洗,超微粉至10~20μm;
6)将步骤5)所得产物加1.5~2.0倍重量份水,浸泡15~20分钟,25~30℃,1500~2000转/分钟,离心5~10分钟;
7)收集步骤6)离心所得上层清液,浓缩至含水量35~50wt%;
8)将步骤4)所得产物加入到步骤7)所得产物中,得混合药膏,加入5~10wt%的辅料,混合均匀,干燥制剂。
4.根据权利要求3所述的一种提高人体免疫力的中药组合物的制备方法,其特征在于,所述步骤2)中超声提取的具体工艺条件为:80~85℃,1200~1500瓦,提取时间30~45分钟。
5.根据权利要求3所述的一种提高人体免疫力的中药组合物的制备方法,其特征在于,所述步骤3)中微波提取的工艺条件为:65~75℃,250~300瓦,提取时间15~20分钟,料液比为1克:25~30毫升。
6.根据权利要求3所述的一种提高人体免疫力的中药组合物的制备方法,其特征在于,所述步骤4)中干燥为45~50℃,真空烘干2~3小时。
7.根据权利要求3所述的一种提高人体免疫力的中药组合物的制备方法,其特征在于,所述步骤8)中辅料为蔗糖、糊精、甘露醇和聚PEG4000中的一种或一种以上的任意组合。
8.根据权利要求3~7任一项所述的一种提高人体免疫力的中药组合物的制备方法,其特征在于,所述步骤8)中的制剂包括汤剂、颗粒剂、片剂、胶囊剂、粉剂、膏剂和丸剂。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2016100753132 | 2016-02-03 | ||
CN201610075313 | 2016-02-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105902827A true CN105902827A (zh) | 2016-08-31 |
Family
ID=56748005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610310558.9A Pending CN105902827A (zh) | 2016-02-03 | 2016-05-12 | 提高人体免疫力的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105902827A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108835622A (zh) * | 2018-06-23 | 2018-11-20 | 刘道灵 | 一种具有增强免疫功能的石斛组合物及其制备方法 |
WO2020014745A1 (en) * | 2018-07-18 | 2020-01-23 | Mycelium Biotech Assets Pty Ltd | Bioactive extract |
CN112057546A (zh) * | 2020-09-08 | 2020-12-11 | 广东都市菜族农业科技有限公司 | 一种蜂胶灵芝孢子粉组合物及其制备方法和应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1899363A (zh) * | 2006-07-21 | 2007-01-24 | 吴方忠 | 一种增强免疫的中药组合物及其制备方法 |
CN103734428A (zh) * | 2013-12-31 | 2014-04-23 | 青岛恒波仪器有限公司 | 一种提高免疫力的女贞子保健茶及其制备方法 |
CN103783623A (zh) * | 2014-02-18 | 2014-05-14 | 扈建民 | 一种提供人体活力的中药组方及其制备方法 |
CN103860906A (zh) * | 2014-03-26 | 2014-06-18 | 庞传武 | 一种提高免疫力的组合物 |
CN104187623A (zh) * | 2014-08-07 | 2014-12-10 | 温素丽 | 一种提高免疫力的保健食品 |
-
2016
- 2016-05-12 CN CN201610310558.9A patent/CN105902827A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1899363A (zh) * | 2006-07-21 | 2007-01-24 | 吴方忠 | 一种增强免疫的中药组合物及其制备方法 |
CN103734428A (zh) * | 2013-12-31 | 2014-04-23 | 青岛恒波仪器有限公司 | 一种提高免疫力的女贞子保健茶及其制备方法 |
CN103783623A (zh) * | 2014-02-18 | 2014-05-14 | 扈建民 | 一种提供人体活力的中药组方及其制备方法 |
CN103860906A (zh) * | 2014-03-26 | 2014-06-18 | 庞传武 | 一种提高免疫力的组合物 |
CN104187623A (zh) * | 2014-08-07 | 2014-12-10 | 温素丽 | 一种提高免疫力的保健食品 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108835622A (zh) * | 2018-06-23 | 2018-11-20 | 刘道灵 | 一种具有增强免疫功能的石斛组合物及其制备方法 |
WO2020014745A1 (en) * | 2018-07-18 | 2020-01-23 | Mycelium Biotech Assets Pty Ltd | Bioactive extract |
US11857587B2 (en) | 2018-07-18 | 2024-01-02 | Mycelium Biotech Assets Pty Ltd | Bioactive extract |
CN112057546A (zh) * | 2020-09-08 | 2020-12-11 | 广东都市菜族农业科技有限公司 | 一种蜂胶灵芝孢子粉组合物及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101732683A (zh) | 一种治疗面部黄褐斑的中药制剂及其制备方法 | |
CN103990081B (zh) | 一种中药组合物及其在制备治疗婴幼儿黄疸药物中的用途 | |
CN105902827A (zh) | 提高人体免疫力的中药组合物及其制备方法 | |
CN108653434A (zh) | 一种治疗脾虚痰湿型多囊卵巢综合征的药物组合物 | |
CN104887747A (zh) | 一种治疗脑血栓的中药组合物及其制备方法 | |
CN104083640A (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN103845607A (zh) | 一种预防治疗糖尿病的复方中药制剂及制备方法 | |
CN104815243A (zh) | 一种萎缩性阴道炎外洗液制备方法 | |
CN104644967A (zh) | 一种治疗i型糖尿病的药物组合物及其应用 | |
CN103127272A (zh) | 一种治疗乳腺疾病的中药制剂及其制备方法 | |
CN105362645A (zh) | 一种制备治疗口腔炎症的药物组合物的方法 | |
CN104606484A (zh) | 一种治疗气血虚的中药组合物及其制备方法 | |
CN104162090B (zh) | 一种药物组合物及其制备方法 | |
CN103110743B (zh) | 一种治疗或预防神经衰弱的中药组合物及其制备方法 | |
CN101385838B (zh) | 一种用于治疗少精子症的补肾生精制剂及其制备方法 | |
CN111110782B (zh) | 一种中药组合物在制备治疗感冒药物中的应用 | |
CN1087012A (zh) | 海特神龙康 | |
CN107625863B (zh) | 治疗风湿骨病的复方中药软胶囊及其制备方法 | |
CN105943860A (zh) | 一种用于治疗糖尿病的药物制剂及其制备方法 | |
CN104623428A (zh) | 一种缓解遗传性酪氨酸血症的中药制剂及其制备方法 | |
CN1205950C (zh) | 治疗再生障碍性贫血胶囊及其制备工艺 | |
CN103768251B (zh) | 一种杀灭血液细胞中病毒、提高人体抗体免疫力的药物 | |
CN105770815A (zh) | 一种含有艾叶的治疗产后虚脱的中药组合物及其制备方法 | |
CN105311419A (zh) | 一种治疗口腔炎症的中药组合物及其制备方法 | |
CN105497783A (zh) | 一种中药制剂在制备治疗气滞血瘀型黄褐斑药物中的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160831 |
|
RJ01 | Rejection of invention patent application after publication |